| |
| |
|
| Insider
Information: |
Xstelos Corp. |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
4,717,666 |
|
|
Indirect Shares
|
8,033,264 |
|
|
| Direct
Value |
$393,689 |
|
|
|
Indirect Value
|
$159,726 |
|
|
| Total
Shares |
12,750,930 |
|
|
| Total
Value |
$553,415 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
0.0
|
| Percentage
Gain/Loss : |
 44.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myrexis Inc |
MYRX |
10% Owner |
|
0 |
2013-02-27 |
7,000,000 |
Premium* |
|
|
Enzon Pharmaceuticals Inc |
ENZN |
10% Owner |
2020-03-26 |
4,717,666 |
2020-03-26 |
1,033,264 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENZN |
Enzon Pharmaceuticals In... |
10% Owner |
– – • |
2020-03-26 |
4 |
B |
$0.14 |
$22,510 |
I/I |
160,785 |
633,264 |
1.5 |
% |
|
| ENZN |
Enzon Pharmaceuticals In... |
10% Owner |
– – • |
2020-03-25 |
4 |
B |
$0.14 |
$65,737 |
I/I |
469,551 |
472,479 |
1.5 |
% |
|
| ENZN |
Enzon Pharmaceuticals In... |
10% Owner |
– – • |
2020-03-23 |
4 |
B |
$0.14 |
$375 |
I/I |
2,678 |
2,928 |
1.42 |
% |
|
| ENZN |
Enzon Pharmaceuticals In... |
10% Owner |
– – • |
2020-03-13 |
4 |
B |
$0.14 |
$2,661 |
I/I |
19,709 |
1,594,232 |
1.42 |
% |
|
| ENZN |
Enzon Pharmaceuticals In... |
10% Owner |
– – • |
2019-02-11 |
4 |
B |
$0.25 |
$9,000 |
D/D |
36,000 |
4,717,666 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
10% Owner |
– – • |
2019-02-11 |
4 |
B |
$0.25 |
$3,750 |
I/I |
15,000 |
1,574,523 |
1.42 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2019-01-07 |
4 |
B |
$0.26 |
$510 |
D/D |
2,000 |
4,681,666 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2019-01-04 |
4 |
B |
$0.26 |
$638 |
D/D |
2,500 |
4,679,666 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2019-01-03 |
4 |
B |
$0.26 |
$1,148 |
D/D |
4,500 |
4,677,166 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-12-21 |
4 |
B |
$0.27 |
$84,100 |
I/I |
312,523 |
1,559,523 |
1.5 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-12-20 |
4 |
B |
$0.24 |
$50,419 |
I/I |
213,189 |
1,247,000 |
1.5 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-12-19 |
4 |
B |
$0.23 |
$3,510 |
I/I |
15,261 |
1,033,811 |
1.42 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-12-07 |
4 |
B |
$0.22 |
$550 |
I/I |
2,500 |
1,018,550 |
1.42 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-12-06 |
4 |
B |
$0.22 |
$242 |
I/I |
1,100 |
1,016,050 |
1.42 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-12-04 |
4 |
B |
$0.22 |
$99 |
I/I |
450 |
1,014,950 |
1.42 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-12-03 |
4 |
B |
$0.22 |
$9,339 |
I/I |
42,450 |
1,014,500 |
1.5 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-11-21 |
4 |
B |
$0.22 |
$8,811 |
I/I |
40,050 |
972,050 |
1.5 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-11-19 |
4 |
B |
$0.22 |
$3,294 |
I/I |
15,000 |
932,000 |
1.42 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-11-16 |
4 |
B |
$0.21 |
$525 |
I/I |
2,500 |
917,000 |
1.42 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-11-15 |
4 |
B |
$0.21 |
$21,000 |
I/I |
100,000 |
914,500 |
1.5 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-11-12 |
4 |
B |
$0.21 |
$21,000 |
I/I |
100,000 |
814,500 |
1.5 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-08-20 |
4 |
B |
$0.26 |
$17,472 |
D/D |
67,200 |
4,672,666 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-08-16 |
4 |
B |
$0.26 |
$2,277 |
D/D |
8,800 |
4,605,466 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-08-15 |
4 |
B |
$0.26 |
$5,253 |
D/D |
20,600 |
4,596,666 |
2.37 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
– – • |
2018-08-14 |
4 |
B |
$0.26 |
$936 |
D/D |
3,671 |
4,576,066 |
2.37 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
